Potassium channel inhibitors

Details for Australian Patent Application No. 2005267884 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Manley, Peter J.; Dinsmore, Christopher J.; Isaacs, Richard; Balitza, Adrienne E.; Neilson, Lou Anne; Nanda, Kausik K.; Wu, Zhicai; Beshore, Douglas C.; Trotter, B. Wesley; Bilodeau, Mark T.; Bergman, Jeffrey M.; Payne, Linda S.

Agent Spruson & Ferguson

Pub. Number AU-B-2005267884

PCT Pub. Number WO2006/015159

Priority 60/592,177 29.07.04 US

Filing date 27 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 21 April 2011

International Classifications

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015159 Priority application(s): WO2006/015159

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

21 April 2011 Application Accepted

  Published as AU-B-2005267884

18 August 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267885-Optimized ball bat

2005267883-Indanone potentiators of metabotropic glutamate receptors